1-3 of 3
Ronit Marcus
Close
Sort by
Journal Articles

The Impact of Cardiovascular Vulnerabilities in Non Hodgkin Lymphoma Patients Treated with Chimeric Antigen Receptor T Cell Therapy

Ivan Landego, Jessica R Flynn, Adam Goldman, Sean M. Devlin, Efrat Luttwak, Alejandro Luna De Abia, Magdalena Corona, Meirav Kedmi, Inbal Sdayoor, Shalev Fried, Noga Shem-Tov, Avichai Shimoni, Ivetta Danylesko, Mohammad Hammoud, Ronit Yerushalmi, Arnon Nagler, Ronit Marcus, Ahmed El-Moghraby, Mahin Rehman, Parastoo B. Dahi, Sergio A. Giralt, Richard J. Lin, Maria Lia Palomba, Michael Scordo, Gunjan L. Shah, Miguel-Angel Perales, Syed Mahmood, Abraham Avigdor, Jennifer Liu, Roni Shouval
Journal: Blood
Blood (2023) 142 (Supplement 1): 6908.
https://doi.org/10.1182/blood-2023-187338
Published: 2023
Journal Articles

High Response Rates Following Point-of-Care Anti-CD19 CAR T-Cell Therapy in Adults with Relapsed/Refractory Acute B Lymphoblastic Leukemia

Shalev Fried, Ivetta Danylesko, Ronit Marcus, Orit Itzhaki, Ronit Yerushalmi, Noga Shem-Tov, Inbal Sdayoor, Roni Shouval, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Avichai Shimoni, Abraham Avigdor
Journal: Blood
Blood (2023) 142 (Supplement 1): 6875.
https://doi.org/10.1182/blood-2023-178477
Published: 2023
Journal Articles

Pre-Treatment Pulmonary Assessment Have Limited Utility in B-Cell Lymphoma Patients Treated with Autologous Anti-CD19 CAR T-Cell Therapy

Inbal Sdayoor, Roni Shouval, Shalev Fried, Ronit Marcus, Ivetta Danylesko, Ronit Yerushalmi, Noga Shem-Tov, Orit Itzhaki, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Avichai Shimoni, Michael J Segel, Abraham Avigdor
Journal: Blood
Blood (2023) 142 (Supplement 1): 3519.
https://doi.org/10.1182/blood-2023-180115
Published: 2023